1. Lesher GY, Forelich ED, Gruet MD, et al.: 1,8-Naphthyridine derivatives. A new class of chemotherapeutic agents. J Med Pharm Chem 1962, 5:1063–1068.
2. Ronald AR, Turck M, Petersdorf RG: A critical evaluation of nalidixic acid in urinary-tract infections. N Engl J Med 1966, 275:1081–1089.
3. King DE, Malone R, Lilley SH: New classification and update on the quinolone antibiotics. Am Fam Physician 2000, 61:2741–2748. Topics in this update on quinolone classification include general clinical indications for old and new quinolones, quinolone pharmacokinetics, and potential adverse effects associated with quinolone use.
4. Read RC, Morrissey I, Ambler JE: Clinicians manual on respiratory tract infections and fluoroquinolones. London, UK: Science Press; 2000.
5. Hooper DC, Wolfson JS: Norfloxacin, ciprofloxacin, and ofloxacin: current clinical roles. Curr Clin Top Infect Dis 1989, 10:194–240.